Disturbed Myeloperoxidase-Dependent Activity of Neutrophils in Cystic Fibrosis Homozygotes and Heterozygotes, and Its Correction by Amiloride

Journal of Immunology

Volumn 157, Issue 6, 1996, Pages 2728-2735

  Witko Sarsat, Véronique ^a,c   Allen, Robert C ^b   Paulais, Marc ^a,d   Nguyen, Anh Thu ^a   Bessou, Gilles ^a   Lenoir, Gérard ^a   Descamps Latscha, Béatrice ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Severance and Associates   (United States)

^c Severance and Associates PA ^*

^d BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; PEROXIDASE;

ADOLESCENT; ARTICLE; CHILD; CYSTIC FIBROSIS; ENZYMOLOGY; FEMALE; GENETICS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MALE; NEUTROPHIL; PHYSIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; AMILORIDE; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; NEUTROPHILS; PEROXIDASE;

EID: 0030587191     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Boat, T. F., M. J. Welsh, and A. L. Beaudet. 1989. Cystic fibrosis. In The Metabolic Basis of Inherited Disease. R. Scriver, A. L. Beaudet, W. S. Ly, and D. Valle, eds. McGraw-Hill, New York, p. 2649.
2. Riordan, J. R., J. M. Rommens, B. S. Kerem, N. Alon, R. Rozmahel, Z. Grzelczak, J. Zielenski, S Lok, N. Plavsic, J. L. Chou, M. L. Drumm, M. C. Iannuzzi, F. S. Collins, and L. C. Tsui. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066.
3. Welsh, M. J., and A. E. Smith. 1993. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73:1251.
4. Konstan, M. W., and M. Berger. 1993. Infection and inflammation in cystic fibrosis. In Cystic Fibrosis. P. B. Davis, ed. Marcel Dekker, New York, p. 219.
5. Khan, T. Z., J. S. Wagner, T. Bost, J. Martinez, F. J. Accurso, and D. W. H. Riches. 1995. Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151:1075.
6. Cantin, A. 1995. Cystic fibrosis lung inflammation: early, sustained and severe. Am. J. Respir. Crit. Care Med. 151:939.
7. Weiss, S. J. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320:365.
8. Döring, G. 1994. The role of neutrophil elastase in chronic inflammation. Am. J. Respir. Crit. Care Med. 150:S114.
9. Allen, R. C., R. L. Stjernholm, and R. H. Steele. 1972. Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem. Biophys. Res. Commun. 47:679.
10. Babior, B. M. 1978. Oxygen-dependent microbial killing by phagocytes. N. Engl. J. Med. 298:659.
11. Nathan, C. F. 1987. Neutrophil activation on biological surfaces: massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J. Clin. Invest. 80:1550.
12. Klebanoff, S. J. 1969. Myeloperoxidase-halide-hydrogen peroxide anti-bacterial system. J. Bacteriol. 95:2131.
13. Allen, R. C. 1975. Halide dependence of the myeloperoxidase-mediated antimicrobial system of the polymorphonuclear leukocyte in the phenomenon of electronic excitation. Biochem. Biophys. Res. Commun. 63:675.
14. Steinbeck, M. J., A. U. Khan, and M. J. Karnovsky. 1992. Intracellular singlet oxygen generation by phagocytosing neutrophils in response to particles coated with a chemical trap. J. Biol. Chem. 267:13425.
15. Zgliczynski, J. M., and T. Stelmaszynska. 1975. Chlorinating ability of human phagocytosing leukocytes. Eur. J. Biochem. 56:157.
16. Weiss, S. J., M. B. Lampert, and S. T. Test. 1983. Long-lived oxidants generated by human neutrophils: characterization and bioactivity. Science 222:623.
17. Suter, S. 1986. Imbalance between polymorphonuclear leukocyte proteases and antiproteases in chronic pyogenic infections and its relation to the proteolysis of complement component C3. Complement 3:1.
18. Birrer, P., N. G. McElvaney, A. Reberg, C. Wirz Sommer, S. Liechti-Gallati, R. Kraemer, R. Hubbard, and R. G. Crystal. 1994. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 150:207.
19. Brown, R., and F. J. Kelly. 1994. Role of free radicals in the pathogenesis of cystic fibrosis. Thorax 49:738.
20. Knowles, M. R., N. L. Church, W. E. Waltner, J. R. Yankaskas, P. Gilligan, M. King, L. J. Edwards, R. W. Helms and R. C. Boucher. 1990. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N. Engl. J. Med. 322:1189.
21. App, E. M., M. King, R. Helfesrieder, D. Kohler, and H. Matthys. 1990. Acute and long-term amiloride inhalation in cystic fibrosis lung disease: a rational approach to cystic fibrosis therapy. Am. Rev. Respir. Dis. 141:605.
22. Zielenski, J. R., R. Rozmahel, D. Bozon, B-S. Kerem, Z. Grzelczak, J. R. Riordan, J. Rommens, and L-C. Tsui. 1991. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 10:214.
23. Nguyen, A. T., R. Golub, M. N. Feuillet-Fieux, and B. Descamps-Latscha. 1983. Modulation of human granulocyte and monocyte chemiluminescence responses: evidence for distinct free radical generating systems. J. Clin. Lab. Immunol. 12: 47.
24. Allen, R. C. 1986. Phagocytic leukocyte oxygenation activities and chemiluminescence: a kinetic approach. Methods Enzymol. 133:449.
25. Bass, D. A., J. W. Parce, L. R. DeChatelet, P. Szejda, and M. C. Thomas. 1983. Flow cytometry studies of oxidative products formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 130:1910.
26. Witko, V., A. T. Nguyen, and B. Descamps-Latscha. 1992. Microtiter plate assay for phagocyte-derived taurine-chloramines. J. Clin. Lab. Anal. 6:47.
27. Kleyman, E. J., and E. J. Cragoe, Jr. 1988. Amiloride and its analogs as tool in the study of ion transport. J. Membr. Biol. 105:1.
28. Rosengren, S., P. M. Henson, and G. S. Worthen. 1994. Migration-associated volume changes in neutrophils facilitate the migratory process in vitro. Am. J. Physiol. 267:C1623.
29. Gallin, E. K., and S. Grinstein. 1992. Ion channel and carriers in leukocytes: distribution and functional role. In Inflammation: Basic Principles and Clinical Correlates. J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds. Raven Press, New York, p. 441.
30. Fittschen, C., and P. M. Henson. 1991. Selective secretion of azurophil granule contents induced by monovalent cation ionophores in human neutrophils: evidence for direct ionophore effects on the granule membrane. J. Leukocyte Biol. 50:517.
31. Bangalore, N., and J. Travis. 1994. Comparison of properties of membrane bound versus soluble forms of human leukocytic elastase and cathepsin. Biol. Chem. Hoppe-Seyler 375:659.
32. Yoshimura, K., H. Nakamura, B. C. Trapnell, C. S. Chu, W. Dalemans, A. Pavirani, J. P. Lecocq, and R. G. Crystal. 1991. Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin. Nucleic Acids Res. 19:5417.
33. Allen, R. C., and D. L. Stevens. 1992. The circulating phagocyte reflects the in vivo state of immune defense. Curr. Opin. Infect. Dis. 5:389.
34. Stevens, D. L., A. E. Bryant, J. Huffman, K. Thompson, and R. C. Allen. 1994. Analysis of circulating phagocyte activity measured by whole blood luminescence: correlation with clinical status. J. Infect. Dis. 170:1463.
35. Kuijpers, T. W., A. T. Tool, C. E. Van Der Schoot, L. A. Ginsel, J. J. Onderwater, D. Roos, and A. J. Verhoeven. 1991. Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface marker for neutrophil activation. Blood 78:1105.
36. Orzalesi, M. M., D. Kohner, C. D. Cook, and H. Schwachman. 1963. Anamnesis, sweat electrolyte and pulmonary function studies in parents of patients with cystic fibrosis of the pancreas. Acta Paediatr. 52:267.
37. Davies, P. B., and K. Vargo. 1987. Pulmonary abnormalities in obligate heterozygotes for cystic fibrosis. Thorax 42:120.
38. Schroeder, S. A., D. M. Gaugham, and M. Swift. 1995. Protection against bronchial asthma by CFTR ΔF508 mutation: a heterozygote advantage in cystic fibrosis. Nat. Med. 1:703.
39. Regelmann, W. E., N. M. Lunde, P. T. Porter, and P. G. Quie. 1986. Increased monocyte chemiluminescence in cystic fibrosis patients and in their parents. Pediatr. Res. 20:619.
40. Roberts, R. L., and R. Stiehm. 1989. Increased phagocytic cell chemiluminescence in patients with cystic fibrosis. Am. J. Dis. Child 143:944.
41. Graft, D. F., E. Mischler, P. M. Farrell, and W. Busse. 1982. Granulocyte chemiluminescence in adolescent patients with cystic fibrosis. Am. Rev. Respir. Dis. 125:540.
42. Jones, M. M., D. K. Seilheimer, G. B. Pier, and R. D. Rossen. 1990. Increased elastase secretion by peripheral blood monocytes in cystic fibrosis patients. Clin. Exp. Immunol. 80:344.
43. Koller, D. Y., R. Urbanek, and M. Götz. 1995. Increased degranulation of eosinophil and neutrophil granulocyles in cystic fibrosis. Am. J. Respir. Crit. Care Med 152:629.
44. Simchowitz, L. 1985. Intracellular pH modulates the generation of superoxide radicals by human neutrophils. J. Clin. Invest. 76:1079.
45. Grinstein, S., B. Elder, and W. Furuya. 1985. Phorbol-ester-induced changes in cytoplasmic pH in neutrophils. Am. J. Physiol. 248:C379.
46. Witko-Sarsat, V., C. Delacourt, D. Rabier, J. Bardet, A. T. Nguyen, and B. Descamps-Latscha. 1995. Neutrophil-derived long-lived oxidants in cystic fibrosis sputum. Am. J. Respir. Crit. Care Med. 152:1910.
47. Borregaard, N., J. H. Schwartz, and A. I. Tauber. 1984. Proton secretion by stimulated neutrophils: significance of hexose monophosphate shunt activity as source of electrons and protons for the respiratory burst. J. Clin. Invest. 74:455.
48. Allen, R. C. 1975. The role of pH in the chemiluminescent response of the myeloperoxidase-halide-HOOH antimicrobial system. Biochem. Biophys. Res. Commun. 63:684.
49. Allen, R. C. 1994. Role of oxygen in phagocyte microbicidal action. Environ. Health Perspect. 102(Suppl. 10):201.
50. + -selective conductance in neutrophils. J. Cell. Physiol. 165:588.